Key result
ECMO rescues a 22-year-old woman with refractory cardiogenic shock due to catastrophic antiphospholipid syndrome.
Why the study?
Does extracorporeal membrane oxygenation (ECMO) improve survival in a patient with refractory cardiogenic shock due to catastrophic antiphospholipid syndrome?
Case Report (n=1)
No
Does extracorporeal membrane oxygenation (ECMO) improve survival in a patient with refractory cardiogenic shock due to catastrophic antiphospholipid syndrome?
ECMO can be successfully utilized as a life-saving intervention for refractory cardiogenic shock secondary to catastrophic antiphospholipid syndrome.
Answers are grounded in this paper and cite their sources.
ECMO may be feasible in refractory shock from catastrophic antiphospholipid syndrome; leaves open survival benefit and generalizability.
Letters5 October 2010Successful Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock Due to the Catastrophic Antiphospholipid SyndromeXavier Repéssé, MD, Yonathan Freund, MD, Alexis Mathian, MD, PhD, Baptiste Hervier, MD, Zahir Amoura, MD, and Charles-Edouard Luyt, MD, PhDXavier Repéssé, MDFrom Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique–Hôpitaux de Paris, Université Paris 6–Pierre-et-Marie-Curie, 75651 Paris, France., Yonathan Freund, MDFrom Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique–Hôpitaux de Paris, Université Paris 6–Pierre-et-Marie-Curie, 75651 Paris, France., Alexis Mathian, MD, PhDFrom Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique–Hôpitaux de Paris, Université Paris 6–Pierre-et-Marie-Curie, 75651 Paris, France., Baptiste Hervier, MDFrom Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique–Hôpitaux de Paris, Université Paris 6–Pierre-et-Marie-Curie, 75651 Paris, France., Zahir Amoura, MDFrom Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique–Hôpitaux de Paris, Université Paris 6–Pierre-et-Marie-Curie, 75651 Paris, France., and Charles-Edouard Luyt, MD, PhDFrom Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique–Hôpitaux de Paris, Université Paris 6–Pierre-et-Marie-Curie, 75651 Paris, France.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-153-7-201010050-00027 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: The catastrophic antiphospholipid syndrome (CAPS), an unusual presentation of the antiphospholipid syndrome (APS), has a high mortality rate, one of the main causes of death being acute cardiac failure. Extracorporeal membrane oxygenation (ECMO) has successfully been used in patients with refractory heart failure but has never been described in patients with CAPS.Objective: To report successful use of ECMO in a patient with refractory cardiogenic shock due to CAPS.Case Report: A 22-year-old woman developed deep venous thrombosis 8 years ago, which was diagnosed as primary APS and treated with warfarin. Since then, she had had no other thromboembolic ...References1. Asherson RA. The catastrophic antiphospholipid syndrome [Editorial]. J Rheumatol. 1992;19:508-12. [PMID: 1593568] MedlineGoogle Scholar2. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al; Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530-4. [PMID: 12892393] CrossrefMedlineGoogle Scholar3. Asherson RA. The catastrophic antiphospholipid (Asherson's) syndrome in 2004—a review. Autoimmun Rev. 2005;4:48-54. [PMID: 15652779] CrossrefMedlineGoogle Scholar4. Bucciarelli S, Cervera R, Espinosa G, Gómez-Puerta JA, Ramos-Casals M, Font J. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun Rev. 2006;6:72-5. [PMID: 17138246] CrossrefMedlineGoogle Scholar5. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al; Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-27. [PMID: 11953980] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Xavier Repéssé, MD; Yonathan Freund, MD; Alexis Mathian, MD, PhD; Baptiste Hervier, MD; Zahir Amoura, MD; Charles-Edouard Luyt, MD, PhDAffiliations: From Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique–Hôpitaux de Paris, Université Paris 6–Pierre-et-Marie-Curie, 75651 Paris, France.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomesSystemic lupus and catastrophic antiphospholipid syndrome manifesting as cardiogenic shockA case of catastrophic antiphospholipid syndrome: first report with advanced cardiac imaging using MRIBack from the Brink: Catastrophic Antiphospholipid SyndromeSyndrome des antiphospholipidesAutoimmune diseases in the intensive care unit. An updateUsefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shockLe syndrome catastrophique des antiphospholipides 5 October 2010Volume 153, Issue 7Page: 487-488KeywordsAntiphospholipid syndromeExtracorporeal membrane oxygenationHeart failureLaparoscopyLeft ventricular ejection fractionLungsPlateletsRespiratory failureShockTroponin ePublished: 5 October 2010 Issue Published: 5 October 2010 Copyright & PermissionsCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Repessé et al. (2010) conducted a case report in Refractory cardiogenic shock due to catastrophic antiphospholipid syndrome (n=1). Extracorporeal membrane oxygenation (ECMO) was evaluated on Successful treatment of refractory cardiogenic shock. Extracorporeal membrane oxygenation was successfully used to treat a 22-year-old woman with refractory cardiogenic shock due to catastrophic antiphospholipid syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: